268 related articles for article (PubMed ID: 28816933)
1. Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study.
Crandall CJ; Hovey KM; Andrews CA; Chlebowski RT; Stefanick ML; Lane DS; Shifren J; Chen C; Kaunitz AM; Cauley JA; Manson JE
Menopause; 2018 Jan; 25(1):11-20. PubMed ID: 28816933
[TBL] [Abstract][Full Text] [Related]
2. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
Rossouw JE; Anderson GL; Prentice RL; LaCroix AZ; Kooperberg C; Stefanick ML; Jackson RD; Beresford SA; Howard BV; Johnson KC; Kotchen JM; Ockene J;
JAMA; 2002 Jul; 288(3):321-33. PubMed ID: 12117397
[TBL] [Abstract][Full Text] [Related]
3. Comparison of clinical outcomes among users of oral and transdermal estrogen therapy in the Women's Health Initiative Observational Study.
Crandall CJ; Hovey KM; Andrews C; Cauley JA; Stefanick M; Shufelt C; Prentice RL; Kaunitz AM; Eaton C; Wactawski-Wende J; Manson JE
Menopause; 2017 Oct; 24(10):1145-1153. PubMed ID: 28697036
[TBL] [Abstract][Full Text] [Related]
4. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.
Manson JE; Chlebowski RT; Stefanick ML; Aragaki AK; Rossouw JE; Prentice RL; Anderson G; Howard BV; Thomson CA; LaCroix AZ; Wactawski-Wende J; Jackson RD; Limacher M; Margolis KL; Wassertheil-Smoller S; Beresford SA; Cauley JA; Eaton CB; Gass M; Hsia J; Johnson KC; Kooperberg C; Kuller LH; Lewis CE; Liu S; Martin LW; Ockene JK; O'Sullivan MJ; Powell LH; Simon MS; Van Horn L; Vitolins MZ; Wallace RB
JAMA; 2013 Oct; 310(13):1353-68. PubMed ID: 24084921
[TBL] [Abstract][Full Text] [Related]
5. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.
Anderson GL; Limacher M; Assaf AR; Bassford T; Beresford SA; Black H; Bonds D; Brunner R; Brzyski R; Caan B; Chlebowski R; Curb D; Gass M; Hays J; Heiss G; Hendrix S; Howard BV; Hsia J; Hubbell A; Jackson R; Johnson KC; Judd H; Kotchen JM; Kuller L; LaCroix AZ; Lane D; Langer RD; Lasser N; Lewis CE; Manson J; Margolis K; Ockene J; O'Sullivan MJ; Phillips L; Prentice RL; Ritenbaugh C; Robbins J; Rossouw JE; Sarto G; Stefanick ML; Van Horn L; Wactawski-Wende J; Wallace R; Wassertheil-Smoller S;
JAMA; 2004 Apr; 291(14):1701-12. PubMed ID: 15082697
[TBL] [Abstract][Full Text] [Related]
6. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial.
LaCroix AZ; Chlebowski RT; Manson JE; Aragaki AK; Johnson KC; Martin L; Margolis KL; Stefanick ML; Brzyski R; Curb JD; Howard BV; Lewis CE; Wactawski-Wende J;
JAMA; 2011 Apr; 305(13):1305-14. PubMed ID: 21467283
[TBL] [Abstract][Full Text] [Related]
7. Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.
Prentice RL; Manson JE; Langer RD; Anderson GL; Pettinger M; Jackson RD; Johnson KC; Kuller LH; Lane DS; Wactawski-Wende J; Brzyski R; Allison M; Ockene J; Sarto G; Rossouw JE
Am J Epidemiol; 2009 Jul; 170(1):12-23. PubMed ID: 19468079
[TBL] [Abstract][Full Text] [Related]
8. Vaginal estrogen use and chronic disease risk in the Nurses' Health Study.
Bhupathiraju SN; Grodstein F; Stampfer MJ; Willett WC; Crandall CJ; Shifren JL; Manson JE
Menopause; 2018 Dec; 26(6):603-610. PubMed ID: 30562320
[TBL] [Abstract][Full Text] [Related]
9. Continuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women's Health Initiative Randomized Trial.
Chlebowski RT; Anderson GL; Sarto GE; Haque R; Runowicz CD; Aragaki AK; Thomson CA; Howard BV; Wactawski-Wende J; Chen C; Rohan TE; Simon MS; Reed SD; Manson JE
J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26668177
[TBL] [Abstract][Full Text] [Related]
10. [Risk and benefits of hormone replacement therapy by postmenopausal women. WHI-Study].
Heinemann V; Parhofer K
Internist (Berl); 2003 Jul; 44(7):896-8. PubMed ID: 14631586
[No Abstract] [Full Text] [Related]
11. Estrogen alone and health outcomes in black women by African ancestry: a secondary analyses of a randomized controlled trial.
Chlebowski RT; Barrington W; Aragaki AK; Manson JE; Sarto G; OʼSullivan MJ; Wu D; Cauley JA; Qi L; Wallace RL; Prentice RL
Menopause; 2017 Feb; 24(2):133-141. PubMed ID: 27749739
[TBL] [Abstract][Full Text] [Related]
12. Randomized Trial Evaluation of the Benefits and Risks of Menopausal Hormone Therapy Among Women 50-59 Years of Age.
Prentice RL; Aragaki AK; Chlebowski RT; Rossouw JE; Anderson GL; Stefanick ML; Wactawski-Wende J; Kuller LH; Wallace R; Johnson KC; Shadyab AH; Gass M; Manson JE
Am J Epidemiol; 2021 Feb; 190(3):365-375. PubMed ID: 33025002
[TBL] [Abstract][Full Text] [Related]
13. Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational Study.
Shufelt CL; Merz CN; Prentice RL; Pettinger MB; Rossouw JE; Aroda VR; Kaunitz AM; Lakshminarayan K; Martin LW; Phillips LS; Manson JE
Menopause; 2014 Mar; 21(3):260-6. PubMed ID: 24045672
[TBL] [Abstract][Full Text] [Related]
14. Coronary Artery Calcification (CAC) and Post-Trial Cardiovascular Events and Mortality Within the Women's Health Initiative (WHI) Estrogen-Alone Trial.
Poornima IG; Mackey RH; Allison MA; Manson JE; Carr JJ; LaMonte MJ; Chang Y; Kuller LH;
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079563
[TBL] [Abstract][Full Text] [Related]
15. Coronary heart disease events in the Women's Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Women's Health Initiative randomized clinical trials.
Wild RA; Wu C; Curb JD; Martin LW; Phillips L; Stefanick M; Trevisan M; Manson JE
Menopause; 2013 Mar; 20(3):254-60. PubMed ID: 23435021
[TBL] [Abstract][Full Text] [Related]
16. Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.
Chlebowski RT; Manson JE; Anderson GL; Cauley JA; Aragaki AK; Stefanick ML; Lane DS; Johnson KC; Wactawski-Wende J; Chen C; Qi L; Yasmeen S; Newcomb PA; Prentice RL
J Natl Cancer Inst; 2013 Apr; 105(8):526-35. PubMed ID: 23543779
[TBL] [Abstract][Full Text] [Related]
17. Postmenopausal hormone replacement therapy: scientific review.
Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.
Hulley S; Grady D; Bush T; Furberg C; Herrington D; Riggs B; Vittinghoff E
JAMA; 1998 Aug; 280(7):605-13. PubMed ID: 9718051
[TBL] [Abstract][Full Text] [Related]
19. Women's Health Initiative estrogen plus progestin clinical trial: a study that does not allow establishing relevant clinical risks.
Aedo S; Cavada G; Blümel JE; Chedraui P; Fica J; Barriga P; Brantes S; Irribarra C; Vallejo M; Campodónico Í
Menopause; 2015 Dec; 22(12):1317-22. PubMed ID: 25968833
[TBL] [Abstract][Full Text] [Related]
20. Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials.
Chlebowski RT; Rohan TE; Manson JE; Aragaki AK; Kaunitz A; Stefanick ML; Simon MS; Johnson KC; Wactawski-Wende J; O'Sullivan MJ; Adams-Campbell LL; Nassir R; Lessin LS; Prentice RL
JAMA Oncol; 2015 Jun; 1(3):296-305. PubMed ID: 26181174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
